karib kemipharm

Karib KemiPharm Limited is a UK company dedicated to profitable growth in the field of Pharmaceutical Generic Manufacturing to assist distributors with the benefit of low cost generics, contract manufacture of generic pharmaceuticals, products development of molecules off-patent and/or likely to be off-patent in the near future. 

We also assist Generic distribution in the EC with regulatory study requirements including, Bioavailability, Bioequivalance, Pre-clinical studies and Pilot trials to identify enhanced bio studies. Innovation speed and customer service is our motto.

Karib KemiPharm Limited was founded by Mr K N Patel and Mr K Balu, each with two decades of experience in the Pharmaceutical Industry, from Bulk drugs to Formulations and Distribution to Retailing. We started with two generic Beta lactam products and today have a host of arrangements in various segments of the generic pharmaceutical industry ranging from OTC to Prescription-only medicines covering over 37 different strengths of product.

Today, we contract manufacture for more than 25 customers either in their own label and/or through cross-licensing arrangements which have been established with our customers spread across the European Union, The Baltics, and the Middle East.

• Jacobsen Pharma A/S (20/07/2010)
• Pharma Marketing 2010 (20/07/2010)
• Achieving preferential patient-access through innovative agreements with payers (09/07/2010)

• Cyvex (09/08/2007)
• Biofin (09/08/2007)
• Cipla (09/08/2007)
• Wockhardt (09/08/2007)
• Real Regulatory (09/08/2007)
• Nycomed (08/08/2007)
• Kurtsan (08/08/2007)
• Indoco (08/08/2007)
• Hikma (08/08/2007)